Microphysiological systems (MPS), such as organ-on-chip technology, are a collection of engineering breakthroughs aimed at recreating the structure and function of human organs in a controlled in vitro setting.1 These innovative platforms integrate living human cells and tissue models into microscale bioengineered technology, allowing researchers to study and understand the physiological processes of different organs at a microscopic level.2 MPS are a new alternative method to conventional cell culture that could be used to assess drug efficacy3 and support personalized medicine. 4